Jesús Gómez-Navarro
- Oncology top 1%
- CAR-T cell therapy research 31
- Cancer Immunotherapy and Biomarkers 23
- Immunology top 1%
- Immunotherapy and Immune Responses 19
- T-cell and B-cell Immunology 8
- Genetics top 2%
- Virus-based gene therapy research 26
- Biotechnology top 2%
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 15
- Viral Infectious Diseases and Gene Expression in Insects 9
-
- Monoclonal and Polyclonal Antibodies Research 11
- Co-authors
- Antoni RibasDavid T. CurielC. A. BulanhaguiRonald D. AlvarezLuis H. CamachoDmitri PavlovJohn A. GlaspyBegoña Comı́n-Anduix
- Cited by
- OncologyImmunologyGenetics
- Journals
- Journal of Clinical Oncology (20 papers)Clinical Cancer Research (5 papers)Molecular Therapy (4 papers)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Jesús Gómez-Navarro
71 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 92
- Oncology 2.6k
- Immunology 1.7k
- Genetics 943
- Biotechnology 242
- Molecular Biology 1.3k
Countries citing papers authored by Jesús Gómez-Navarro
This map shows the geographic impact of Jesús Gómez-Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Gómez-Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Gómez-Navarro more than expected).
Fields of papers citing papers by Jesús Gómez-Navarro
This network shows the impact of papers produced by Jesús Gómez-Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Gómez-Navarro. The network helps show where Jesús Gómez-Navarro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jesús Gómez-Navarro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 55 | |
| 2 | 2013 | 14 | |
| 3 | 2011 | 120 | |
| 4 | 2010 | 23 | |
| 5 | 2009 | 163 | |
| 6 | 2008 | 111 | |
| 7 | 2008 | 64 | |
| 8 | 2007 | 16 | |
| 9 | 2007 | 14 | |
| 10 | 2006 | 104 | |
| 11 | 2002 | 29 | |
| 12 | 2001 | 34 | |
| 13 | 2001 | 24 | |
| 14 | A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. | 2000 | 134 |
| 15 | 2000 | 91 | |
| 16 | 2000 | 24 | |
| 17 | 2000 | 48 | |
| 18 | 1999 | 33 | |
| 19 | 1998 | 16 | |
| 20 | 1998 | 50 |
About Jesús Gómez-Navarro
Jesús Gómez-Navarro is a scholar working on Oncology, Immunology and Genetics, having authored 71 papers that have together received 3.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (31 papers), Virus-based gene therapy research (26 papers), Cancer Immunotherapy and Biomarkers (23 papers), Immunotherapy and Immune Responses (19 papers), RNA Interference and Gene Delivery (15 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Viral Infectious Diseases and Gene Expression in Insects (9 papers) and T-cell and B-cell Immunology (8 papers). The work is most often cited by research in Oncology (2.6k citations), Immunology (1.7k citations) and Genetics (943 citations). Jesús Gómez-Navarro has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Antoni Ribas, David T. Curiel, C. A. Bulanhagui, Ronald D. Alvarez, Luis H. Camacho, Dmitri Pavlov, John A. Glaspy, Begoña Comı́n-Anduix, Mack N. Barnes and Waleed Arafat. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Molecular Therapy, Gynecologic Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.